Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma Mice

Abstract
Purpose. Retinal ganglion cell (RGC) loss occurs in response to increased intraocular pressure (IOP) and/or retinal ischemia in glaucoma and leads to impairment of vision. This study was undertaken to test the efficacy of erythropoietin (EPO) in providing neuroprotection to RGCs in vivo.

This publication has 0 references indexed in Scilit: